Atezolizumab vs Memantine

## Atezolizumab vs Memantine: Overview

This comparison examines the pharmacological differences between **Atezolizumab** and **Memantine**.

## Mechanism of Action

**Atezolizumab**: Fully human anti-PD-L1 IgG1 monoclonal antibody blocking PD-L1 interaction with PD-1 and B7.1.

**Memantine**: Non-competitive NMDA receptor antagonist.

## Pharmacokinetics

**Half-life**: Atezolizumab — 27 days; Memantine — 60-80 hours.

## Chemical Properties

**Molecular Formula**: Atezolizumab — N/A; Memantine — C12H21N.

**Molecular Weight**: Atezolizumab — N/A; Memantine — 179.3080 g/mol.

**Type**: Atezolizumab — Antibody; Memantine — Small molecule.